Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E7WH
|
|||
| Drug Name |
KPAX002
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 2 | [1] | |
| Amyotrophic lateral sclerosis [ICD-11: 8B60.0] | Clinical trial | [2] | ||
| Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Clinical trial | [2] | ||
| Company |
K-PAX Pharmaceuticals Mill Valley, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.